Assay ID | Title | Year | Journal | Article |
AID1296008 | Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening | 2020 | SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
| Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening. |
AID1346986 | P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen | 2019 | Molecular pharmacology, 11, Volume: 96, Issue:5
| A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. |
AID1347159 | Primary screen GU Rhodamine qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay | 2020 | Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
| Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors. |
AID1347160 | Primary screen NINDS Rhodamine qHTS for Zika virus inhibitors | 2020 | Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
| Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors. |
AID1346987 | P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen | 2019 | Molecular pharmacology, 11, Volume: 96, Issue:5
| A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. |
AID1408542 | Selectivity ratio of IC50 for HDAC8 (unknown origin) to IC50 for HDAC3 (unknown origin) | 2018 | European journal of medicinal chemistry, Sep-05, Volume: 157 | HDAC3 is a potential validated target for cancer: An overview on the benzamide-based selective HDAC3 inhibitors through comparative SAR/QSAR/QAAR approaches. |
AID1408540 | Selectivity ratio of IC50 for HDAC6 (unknown origin) to IC50 for HDAC3 (unknown origin) | 2018 | European journal of medicinal chemistry, Sep-05, Volume: 157 | HDAC3 is a potential validated target for cancer: An overview on the benzamide-based selective HDAC3 inhibitors through comparative SAR/QSAR/QAAR approaches. |
AID1408538 | Selectivity ratio of IC50 for HDAC2 (unknown origin) to IC50 for HDAC3 (unknown origin) | 2018 | European journal of medicinal chemistry, Sep-05, Volume: 157 | HDAC3 is a potential validated target for cancer: An overview on the benzamide-based selective HDAC3 inhibitors through comparative SAR/QSAR/QAAR approaches. |
AID1622959 | Inhibition of HDAC3 (unknown origin) using peptide substrate measured after 1 hr | 2018 | European journal of medicinal chemistry, Oct-05, Volume: 158 | HDAC as onco target: Reviewing the synthetic approaches with SAR study of their inhibitors. |
AID1602220 | Inhibition of recombinant human HDAC2 using fluorescently-labeled acetylated histone peptide as substrate by microfluidic mobility shift assay | 2019 | European journal of medicinal chemistry, Mar-15, Volume: 166 | Histone deacetylase 3 inhibitors in learning and memory processes with special emphasis on benzamides. |
AID1602222 | Inhibition of recombinant human HDAC4 using fluorescently-labeled acetylated histone peptide as substrate by microfluidic mobility shift assay | 2019 | European journal of medicinal chemistry, Mar-15, Volume: 166 | Histone deacetylase 3 inhibitors in learning and memory processes with special emphasis on benzamides. |
AID1408536 | Inhibition of HDAC3 (unknown origin) | 2018 | European journal of medicinal chemistry, Sep-05, Volume: 157 | HDAC3 is a potential validated target for cancer: An overview on the benzamide-based selective HDAC3 inhibitors through comparative SAR/QSAR/QAAR approaches. |
AID1602225 | Inhibition of recombinant human HDAC8 using fluorescently-labeled acetylated histone peptide as substrate by microfluidic mobility shift assay | 2019 | European journal of medicinal chemistry, Mar-15, Volume: 166 | Histone deacetylase 3 inhibitors in learning and memory processes with special emphasis on benzamides. |
AID1408541 | Selectivity ratio of IC50 for HDAC7 (unknown origin) to IC50 for HDAC3 (unknown origin) | 2018 | European journal of medicinal chemistry, Sep-05, Volume: 157 | HDAC3 is a potential validated target for cancer: An overview on the benzamide-based selective HDAC3 inhibitors through comparative SAR/QSAR/QAAR approaches. |
AID1408539 | Selectivity ratio of IC50 for HDAC4 (unknown origin) to IC50 for HDAC3 (unknown origin) | 2018 | European journal of medicinal chemistry, Sep-05, Volume: 157 | HDAC3 is a potential validated target for cancer: An overview on the benzamide-based selective HDAC3 inhibitors through comparative SAR/QSAR/QAAR approaches. |
AID1408537 | Selectivity ratio of IC50 for HDAC1 (unknown origin) to IC50 for HDAC3 (unknown origin) | 2018 | European journal of medicinal chemistry, Sep-05, Volume: 157 | HDAC3 is a potential validated target for cancer: An overview on the benzamide-based selective HDAC3 inhibitors through comparative SAR/QSAR/QAAR approaches. |
AID1602221 | Inhibition of recombinant human HDAC3 using fluorescently-labeled acetylated histone peptide as substrate by microfluidic mobility shift assay | 2019 | European journal of medicinal chemistry, Mar-15, Volume: 166 | Histone deacetylase 3 inhibitors in learning and memory processes with special emphasis on benzamides. |
AID1602224 | Inhibition of recombinant human HDAC7 using fluorescently-labeled acetylated histone peptide as substrate by microfluidic mobility shift assay | 2019 | European journal of medicinal chemistry, Mar-15, Volume: 166 | Histone deacetylase 3 inhibitors in learning and memory processes with special emphasis on benzamides. |
AID1602223 | Inhibition of recombinant human HDAC6 using fluorescently-labeled acetylated histone peptide as substrate by microfluidic mobility shift assay | 2019 | European journal of medicinal chemistry, Mar-15, Volume: 166 | Histone deacetylase 3 inhibitors in learning and memory processes with special emphasis on benzamides. |
AID1602219 | Inhibition of recombinant human HDAC1 using fluorescently-labeled acetylated histone peptide as substrate by microfluidic mobility shift assay | 2019 | European journal of medicinal chemistry, Mar-15, Volume: 166 | Histone deacetylase 3 inhibitors in learning and memory processes with special emphasis on benzamides. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |